首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 醫療設備 > 導管 > 美國的靜脈通路裝置市場:2011年
產業/市場分類
醫療設備 (4528)
內視鏡檢查設備 (158)
分子呈像/呈影劑 (28)
心血管設備 (335)
可拋式醫學設備 (76)
核子醫學 (80)
病患監測 (382)
眼科設備 (102)
傷口護理 (159)
超音波 (54)
齒科設備 (174)
導管 (232)
整形外科 (335)
醫學影像診斷 (414)
體外診斷設備 (476)
CT/MRI/X光 (172)
e保健 (321)
市場調查報告書

美國的靜脈通路裝置市場:2011年

US Markets for Vascular Access Devices 2011

出版商 Millennium Research Group
出版日期 2010年11月 商品編碼 137805
內容資訊 英文  
價格
US $ 6995 Web Access and PDF Download (Single user license)
US $ 10500 Web Access and PDF Download (Corporate use license)


美國的靜脈通路裝置市場:2011年 是由出版商Millennium Research Group在2010年11月所出版的。 這份英文市場調查報告書價格從美金6995起跳。

簡介

2008年,美國的靜脈通路裝置市場達到超過10億美元的規模。

本報告,提供美國靜脈通路裝置市場的整體概要、末梢靜脈導管•經末梢置入中心靜脈導管•中心靜脈導管•植入式藥盒•透析導管等領域別的市場分析、競爭分析、以及市場預測等,由下列摘要形式闡述。

報告摘要

調查方式

第1章 美國的靜脈通路裝置市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率

第2章 末梢靜脈導管(SHORT CATHETER)市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率
    • 競爭企業分析

第3章 經末梢置入中心靜脈導管(PICC)市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析

第4章 中心靜脈導管市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率
    • 競爭企業分析

第5章 植入式藥盒市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率
    • 競爭企業分析

第6章 透析導管市場

  • 市場概要
  • 市場分析
    • 末期腎臟病(ESRD)
    • 透析導管模式的前提條件
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率
    • 競爭企業分析

第7章 賀伯氏針市場

  • 市場概要
  • 市場分析
    • 裝置的概要
    • 處置
    • 市場預測
    • 市場促進因子・阻礙因子
  • 競爭分析
    • 競爭情勢
    • 市佔率
    • 競爭企業分析

附錄

圖表一覽表

目錄

Abstract

The US vascular access device market comprises mature and developing segments. The continual adoption of antimicrobial-coated central venous catheters (CVCs) and dialysis catheters, as well as increasing adoption of power-injectable models of peripherally inserted central catheters (PICCs) and implantable ports, will contribute to drive revenue growth in this market over the forecast period. In the short peripheral intravenous catheter (PIVC) and Huber needle markets, the majority of sales will be accounted for by safety devices due to the Needlestick Safety and Prevention Act, which aims to prevent needlestick injuries among health care workers. Additionally, the increasing elderly population in the US will expand the potential patient pool for procedures requiring vascular access, such as drug therapies and blood sampling. As a result, the US vascular access device market will experience steady growth through 2015.

METHODOLOGY

RESEARCH METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

  • Government sources:
    • Securities and Exchange Commission filings
    • Food and Drug Administration and patent filings
    • International Database (US Census Bureau)
    • World Population Prospects
    • United States Renal Data System
    • Fistula First Breakthrough Initiative
  • Vascular access device companies:
    • Annual reports, product brochures, corporate profiles, etc.
  • Internal databases and reports:
    • Previous reports on similar/related sources
  • General Internet searches, medical literature, and newspaper/magazine searches:
    • Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various vascular access device market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified. These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

FORECAST METHODOLOGY

In addition to the research methodology outlined above, the following “bottom-up” methodology is used to develop forecast assumptions for the report.

A comprehensive breakdown of various vascular access device procedures and unit sales is prepared using data from several sources, including professional associations, government statistics, and private research/media sources. Industry experts and practitioners are consulted to ensure accuracy and verify observed trends. As a cross-check, total industry revenues available through annual reports and other sources are compared against modeled industry revenues.

Using the best estimates of industry experts, practitioners, private research/media sources, and inhouse experts, year-by-year growth rates and ASPs are applied individually to each subcategory to derive forecasts. These estimates are cross-checked by industry experts (marketing managers, product managers, CEOs, etc.) and further refined.

Overall findings are compared against market and procedure forecasts published by other sources to ensure reasonable estimates.

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 US VASCULAR ACCESS DEVICE MARKET

  • 1.1 Market Overview
  • 1.2 Market Analysis
    • 1.2.1 Device Overview
    • 1.2.2 Procedures
    • 1.2.3 Market Forecast
      • 1.2.3.1 Antimicrobial-Coated Vascular Access Device Market
    • 1.2.4 Market Drivers and Limiters
  • 1.3 Competitive Analysis
    • 1.3.1 Competitive Landscape
    • 1.3.2 Market Shares

2.0 SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET

  • 2.1 Market Overview
  • 2.2 Market Analysis
    • 2.2.1 Device Overview
    • 2.2.2 Procedures
      • 2.2.2.1 Acute Care Short Peripheral Intravenous Catheter Procedures
      • 2.2.2.2 Alternate Care Short Peripheral Intravenous Catheter Procedures
    • 2.2.3 Market Forecast by Setting
      • 2.2.3.1 Acute Care Short Peripheral Intravenous Catheter Market
      • 2.2.3.2 Alternate Care Short Peripheral Intravenous Catheter Market
    • 2.2.4 Market Forecast by Type
      • 2.2.4.1 Safety Short Peripheral Intravenous Catheter Market
      • 2.2.4.2 Standard Short Peripheral Intravenous Catheter Market
    • 2.2.5 Market Drivers and Limiters
  • 2.3 Competitive Analysis
    • 2.3.1 Competitive Landscape
    • 2.3.2 Market Shares
    • 2.3.3 Competitor Discussions (in Alphabetical Order)
      • B. Braun Medical
      • Becton Dickinson
      • Smiths Medical
      • Other

3.0 PERIPHERALLY INSERTED CENTRAL CATHETER MARKET

  • 3.1 Market Overview
  • 3.2 Market Analysis
    • 3.2.1 Device Overview
    • 3.2.2 Procedures
      • 3.2.2.1 Standard Peripherally Inserted Central Catheter Procedures
      • 3.2.2.2 Power-Injectable Peripherally Inserted Central Catheter Procedures
    • 3.2.3 Market Forecast
      • 3.2.3.1 Standard Peripherally Inserted Central Catheter Market
      • 3.2.3.2 Power-Injectable Peripherally Inserted Central Catheter Market
    • 3.2.4 Market Drivers and Limiters
  • 3.3 Competitive Analysis
    • 3.3.1 Competitive Landscape
    • 3.3.2 Market Shares
    • 3.3.3 Competitor Discussions (in Alphabetical Order)
      • AngioDynamics
      • Arrow International (a Teleflex Medical Company)
      • Cook Medical
      • C. R. Bard
      • Navilyst Medical
      • Other

4.0 CENTRAL VENOUS CATHETER MARKET

  • 4.1 Market Overview
  • 4.2 Market Analysis
    • 4.2.1 Device Overview
    • 4.2.2 Procedures
      • 4.2.2.1 Acute Central Venous Catheter Procedures
      • 4.2.2.2 Tunneled Central Venous Procedures
    • 4.2.3 Market Forecast
      • 4.2.3.1 Acute Central Venous Catheter Market
      • 4.2.3.2 Tunneled Central Venous Catheter Market
    • 4.2.4 Market Drivers and Limiters
  • 4.3 Competitive Analysis
    • 4.3.1 Competitive Landscape
    • 4.3.2 Market Shares
    • 4.3.3 Competitor Discussions (in Alphabetical Order)
      • Arrow International (a Teleflex Medical Company)
      • Cook Medical
      • C. R. Bard
      • Edwards Lifesciences
      • Other

5.0 IMPLANTABLE PORT MARKET

  • 5.1 Market Overview
  • 5.2 Market Analysis
    • 5.2.1 Device Overview
    • 5.2.2 Procedures
      • 5.2.2.1 Single-Lumen Implantable Port Procedures
      • 5.2.2.2 Dual-Lumen Implantable Port Procedures
    • 5.2.3 Market Forecast
      • 5.2.3.1 Single-Lumen Implantable Port Market by Injection Type
      • 5.2.3.2 Dual-Lumen Implantable Port Market by Injection Type
    • 5.2.4 Market Drivers and Limiters
  • 5.3 Competitive Analysis
    • 5.3.1 Competitive Landscape
    • 5.3.2 Market Shares
    • 5.3.3 Competitor Discussions (in Alphabetical Order)
      • AngioDynamics
      • C. R. Bard
      • Navilyst Medical
      • Smiths Medical
      • Other

6.0 DIALYSIS CATHETER MARKET

  • 6.1 Market Overview
  • 6.2 Market Analysis
    • 6.2.1 End-Stage Renal Disease
    • 6.2.2 Treatment of End-Stage Renal Disease
      • 6.2.2.1 Hemodialysis
      • 6.2.2.2 Peritoneal Dialysis
      • 6.2.2.3 Kidney Transplant
    • 6.2.3 Dialysis Catheter Model Assumptions
    • 6.2.4 Procedures
      • 6.2.4.1 Acute Dialysis Catheter Procedures
        • Antimicrobial-Coated Acute Dialysis Catheter Procedures
      • 6.2.4.2 Chronic Dialysis Catheter Procedures
    • 6.2.5 Market Forecast
      • 6.2.5.1 Acute Dialysis Catheter Market
        • Antimicrobial-Coated Acute Dialysis Catheter Market
      • 6.2.5.2 Chronic Dialysis Catheter Market
    • 6.2.6 Market Drivers and Limiters
  • 6.3 Competitive Analysis
    • 6.3.1 Competitive Landscape
    • 6.3.2 Market Shares
    • 6.3.3 Competitor Discussions (in Alphabetical Order)
      • AngioDynamics
      • Arrow International (a Teleflex Medical company)
      • Covidien
      • C. R. Bard
      • Medcomp
      • Navilyst Medical
      • Other

7.0 HUBER NEEDLE MARKET

  • 7.1 Market Overview
  • 7.2 Market Analysis
    • 7.2.1 Device Overview
    • 7.2.2 Procedures
    • 7.2.3 Market Forecast
    • 7.2.4 Market Drivers and Limiters
  • 7.3 Competitive Analysis
    • 7.3.1 Competitive Landscape
    • 7.3.2 Market Shares
    • 7.3.3 Competitor Discussions (in Alphabetical Order)
      • AngioDynamics
      • C. R. Bard
      • Smiths Medical
      • Other

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Vascular Access Device Market, by Device Type, as a % of Total, US, 2010
  • Figure 2: Short PIVC Market, by Setting, US (US$), 2009 - 2015
  • Figure 3: PICC Market, by Injection Type, as a % of Total, US, 2010 and 2015
  • Figure 4: CVC Market, by Type, as a % of Total, US, 2010
  • Figure 5: Implantable Port Market, US (US$), 2009 - 2015
  • Figure 6: Dialysis Catheter Market, by Catheter Type, as a % of Total, US, 2010
  • Figure 7: Huber Needle Procedures, by Type, US, 2009 - 2015
  • Table 1: Companies Mentioned in This Report

METHODOLOGY

1.0 US VASCULAR ACCESS DEVICE MARKET

  • Figure 8: Vascular Access Device Market, US (US$), 2009 - 2015
  • Figure 9: Vascular Access Procedures, US, 2009 - 2015
  • Table 2: Vascular Access Procedures, by Device Type, US, 2009 - 2015
  • Figure 10: Vascular Access Device Market, by Device Type, US (US$), 2009 - 2015
  • Table 3: Vascular Access Device Market, by Device Type, US (US$), 2009 - 2015
  • Table 4: Antimicrobial-Coated Vascular Access Device Market, by Device Type, US (US$), 2009 - 2015
  • Table 5: Drivers of the Vascular Access Device Market, US
  • Table 6: Limiters of the Vascular Access Device Market, US
  • Figure 11: Leading Competitors in the Vascular Access Device Market, as a % of Total, US, 2010
  • Table 7: Leading Competitors in the Vascular Access Device Market, by Device Type, as a % of Total, US, 2010

2.0 SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET

  • Figure 12: Short PIVC Market, US (US$), 2009 - 2015
  • Figure 13: Short PIVC Procedures, by Setting, US, 2009 - 2015
  • Table 8: Short PIVC Procedures, by Setting, US, 2009 - 2015
  • Figure 14: Short PIVC Market, by Setting, US (US$), 2009 - 2015
  • Table 9: Short PIVC Market, by Setting, US (US$), 2009 - 2015
  • Table 10: Short PIVC Market Growth, by Setting, US, 2010 - 2015
  • Table 11: Short PIVC Market, by Setting, as a % of Total, US, 2009 - 2015
  • Table 12: Acute Care Short PIVC Market, by Type, US (US$), 2009 - 2015
  • Table 13: Acute Care Short PIVC Market Growth, by Type, US, 2010 - 2015
  • Table 14: Acute Care Short PIVC Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 15: Alternate Care Short PIVC Market, by Type, US (US$), 2009 - 2015
  • Table 16: Alternate Care Short PIVC Market Growth, by Type, US, 2010 - 2015
  • Table 17: Alternate Care Short PIVC Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 18: Safety Short PIVC Market, by Setting, US (US$), 2009 - 2015
  • Table 19: Safety Short PIVC Market Growth, by Setting, US, 2010 - 2015
  • Table 20: Safety Short PIVC Market, by Setting, as a % of Total, US, 2009 - 2015
  • Table 21: Standard Short PIVC Market, by Setting, US (US$), 2009 - 2015
  • Table 22: Standard Short PIVC Market Growth, by Setting, US, 2010 - 2015
  • Table 23: Standard Short PIVC Market, by Setting, as a % of Total, US, 2009 - 2015
  • Table 24: Drivers of the Short PIVC Market, US
  • Table 25: Limiters of the Short PIVC Market, US
  • Table 26: Leading Competitors in the Short PIVC Market, by Type, as a % of Total, US, 2010

3.0 PERIPHERALLY INSERTED CENTRAL CATHETER MARKET

  • Figure 15: PICC Market, by Injection Type, US (US$), 2009 - 2015
  • Figure 16: PICC Procedures, by Injection Type, US, 2009 - 2015
  • Table 27: PICC Procedures, by Injection Type, US, 2009 - 2015
  • Table 28: Standard PICC Procedures, by Operator, US, 2009 - 2015
  • Table 29: Power-Injectable PICC Procedures, by Operator, US, 2009 - 2015
  • Table 30: PICC Market, by Injection Type, US (US$), 2009 - 2015
  • Table 31: PICC Market Growth, by Injection Type, US, 2010 - 2015
  • Table 32: PICC Market, by Injection Type, as a % of Total, US, 2009 - 2015
  • Table 33: Standard PICC Market, by Operator, US (US$), 2009 - 2015
  • Table 34: Standard PICC Market Growth, by Operator, US, 2010 - 2015
  • Table 35: Standard PICC Market, by Operator, as a % of Total, US, 2009 - 2015
  • Table 36: Power-Injectable PICC Market, by Operator, US (US$), 2009 - 2015
  • Table 37: Power-Injectable PICC Market Growth, by Operator, US, 2010 - 2015
  • Table 38: Power-Injectable PICC Market, by Operator, as a % of Total, US, 2009 - 2015
  • Table 39: Drivers of the PICC Market, US
  • Table 40: Limiters of the PICC Market, US
  • Table 41: Leading Competitors in the PICC Market, as a % of Total, US, 2010

4.0 CENTRAL VENOUS CATHETER MARKET

  • Figure 17: CVC Market, by Type, US (US$), 2009 - 2015
  • Figure 18: Acute CVC Procedures, by Coating, US, 2009 - 2015
  • Table 42: CVC Procedures, by Type, US, 2009 - 2015
  • Table 43: Acute CVC Procedures, by Coating, US, 2009 - 2015
  • Table 44: CVC Market, by Type, US (US$), 2009 - 2015
  • Table 45: CVC Market Growth, by Type, US, 2010 - 2015
  • Table 46: CVC Market, by Type, as a % of Total, US, 2009 - 2015
  • Figure 19: Acute CVC Market, by Coating, US (US$), 2009 - 2015
  • Table 47: Acute CVC Market, by Coating, US (US$), 2009 - 2015
  • Table 48: Acute CVC Market Growth, by Coating, US, 2010 - 2015
  • Table 49: Acute CVC Market, by Coating, as a % of Total, US, 2009 - 2015
  • Table 50: Drivers of the CVC Market, US
  • Table 51: Limiters of the CVC Market, US
  • Table 52: Leading Competitors in the CVC Market, by Type, as a % of Total, US, 2010

5.0 IMPLANTABLE PORT MARKET

  • Figure 20: Implantable Port Market, by Lumen Number, US (US$), 2009 - 2015
  • Table 53: Implantable Port Procedures, by Lumen Number, US, 2009 - 2015
  • Figure 21: Single-Lumen Implantable Port Procedures, by Injection Type, US, 2009 - 2015
  • Table 54: Single-Lumen Implantable Port Procedures, by Injection Type, US, 2009 - 2015
  • Figure 22: Dual-Lumen Implantable Port Procedures, by Injection Type, US, 2009 - 2015
  • Table 55: Dual-Lumen Implantable Port Procedures, by Injection Type, US, 2009 - 2015
  • Table 56: Implantable Port Market, by Lumen Number, US (US$), 2009 - 2015
  • Table 57: Implantable Port Market Growth, by Lumen Number, US, 2010 - 2015
  • Table 58: Implantable Port Market, by Lumen-Number, as a % of Total, US, 2009 - 2015
  • Table 59: Single-Lumen Implantable Port Market, by Injection Type, US (US$), 2009 - 2015
  • Table 60: Single-Lumen Implantable Port Market Growth, by Injection Type, US, 2010 - 2015
  • Table 61: Single-Lumen Implantable Port Market, by Injection Type, as a % of Total, US, 2009 - 2015
  • Table 62: Dual-Lumen Implantable Port Market, by Injection Type, US (US$), 2009 - 2015
  • Table 63: Dual-Lumen Implantable Port Market Growth, by Injection Type, US, 2010 - 2015
  • Table 64: Dual-Lumen Implantable Port Market, by Injection Type, as a % of Total, US, 2009 - 2015
  • Table 65: Drivers of the Implantable Port Market, US
  • Table 66: Limiters of the Implantable Port Market, US
  • Table 67: Leading Competitors in the Implantable Port Market, as a % of Total, US, 2010

6.0 DIALYSIS CATHETER MARKET

  • Figure 23: Dialysis Catheter Market, by Catheter Type, US (US$), 2009 - 2015
  • Table 68: Incidence and Prevalence of ESRD, US, 2009 - 2015
  • Table 69: Treatment of ESRD in the Incident Population, by Treatment Type, US, 2009 - 2015
  • Table 70: Treatment of ESRD in the Prevalent Population, by Treatment Type, US, 2009 - 2015
  • Figure 24: Treatment Algorithm for Incident ESRD Population, US, 2010
  • Figure 25: Treatment Algorithm for Prevalent ESRD Population, US, 2010
  • Table 71: Incident ESRD Hemodialysis Cases, by Initial Mode of Vascular Access, US, 2009 - 2015
  • Table 72: Incident ESRD Hemodialysis Cases, by Mode of Vascular Access after 90 Days, US, 2009 - 2015
  • Table 73: Prevalent ESRD Hemodialysis Cases, by Mode of Vascular Access, US, 2009 - 2015
  • Figure 26: Dialysis Catheter Procedures, by Catheter Type, US, 2009 - 2015
  • Table 74: Dialysis Catheter Procedures, by Catheter Type, US, 2009 - 2015
  • Table 75: Acute Dialysis Catheter Procedures, by Coating, US, 2009 - 2015
  • Table 76: Dialysis Catheter Market, by Catheter Type, US (US$), 2009 - 2015
  • Table 77: Dialysis Catheter Market Growth, by Catheter Type, US, 2010 - 2015
  • Table 78: Dialysis Catheter Market, by Catheter Type, as a % of Total, US, 2009 - 2015
  • Table 79: Acute Dialysis Catheter Market, by Coating, US (US$), 2009 - 2015
  • Table 80: Acute Dialysis Catheter Market Growth, by Coating, US, 2010 - 2015
  • Table 81: Acute Dialysis Catheter Market, by Coating, as a % of Total, US, 2009 - 2015
  • Table 82: Drivers of the Dialysis Catheter Market, US
  • Table 83: Limiters of the Dialysis Catheter Market, US
  • Table 84: Leading Competitors in the Dialysis Catheter Market, by Catheter Type, as a % of Total, US, 2010

7.0 HUBER NEEDLE MARKET

  • Figure 27: Huber Needle Market, by Type, US (US$), 2009 - 2015
  • Table 85: Huber Needle Sales as a Function of Chemotherapy Treatment Cycles, US, 2009 - 2015
  • Table 86: Huber Needle Sales, by Type, US, 2009 - 2015
  • Table 87: Safety Huber Needle Sales, by Injection Type, US, 2009 - 2015
  • Table 88: Huber Needle Market, by Type, US (US$), 2009 - 2015
  • Table 89: Huber Needle Market Growth, by Type, US, 2010 - 2015
  • Table 90: Huber Needle Market, by Type, as a % of Total, US, 2009 - 2015
  • Table 91: Safety Huber Needle Market, by Injection Type, US (US$), 2009 - 2015
  • Table 92: Safety Huber Needle Market Growth, by Injection Type, US, 2010 - 2015
  • Table 93: Safety Huber Needle Market, by Injection Type, as a % of Total, US, 2009 - 2015
  • Table 94: Drivers of the Huber Needle Market, US
  • Table 95: Limiters of the Huber Needle Market, US
  • Table 96: Leading Competitors in the Huber Needle Market, as a % of Total, US, 2010

APPENDIX A: MRG ACRONYMS AND INITIALISMS

  • MRG Acronyms and Initialisms

APPENDIX B: SUPPLEMENTAL FIGURES

  • Figure 28: Vascular Access Device Market, by Device Type, as a % of Total, US, 2010 (Detailed Format)
  • Figure 29: Short PIVC Market, by Setting, US (US$), 2009 - 2015 (Detailed Format)
  • Figure 30: PICC Market, by Injection Type, as a % of Total, US, 2010 and 2015 (Detailed Format)
  • Figure 31: CVC Market, by Type, as a % of Total, US, 2010 (Detailed Format)
  • Figure 32: Implantable Port Market, US (US$), 2009 - 2015 (Detailed Format)
  • Figure 33: Dialysis Catheter Market, by Catheter Type, as a % of Total, US, 2010 (Detailed Format)
  • Figure 34: Huber Needle Procedures, by Type, US, 2009 - 2015 (Detailed Format)
Back to Top